Bryonia alba
Bryonia alba · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Bryonia alba is a botanical species known primarily for its medicinal properties derived from the plant's roots. Through various preparations such as aqueous extracts, decoctions, and homeopathic dilutions, it exhibits significant biological activities including cytotoxic and acetylcholinergic effects. The plant contains specialized chemical compounds, most notably Brydioside A, B, and C, along with Bryonoside. Research has focused on its potential application in treating serious conditions such as cancer, AIDS, and Burkitt's lymphoma due to its 5-alpha-reductase-inhibitor properties. However, users should remain cautious as the plant is also classified as allergenic.
- Synonyms
- Bryonia Vulgaris
- Common names
- Not available
- Family
- Cucurbitaceae
- Distribution
- Not available
- Plant Parts
- Root
Classification
Common Names
Bryonia alba is a versatile plant known by a wide variety of regional and linguistic names. In some parts of the world, it is commonly referred to as Brionia bianca or Bryone blanche. It is also frequently called Eastern White-bryony, a name that highlights its distinct appearance. Depending on the local dialect, you might even encounter it listed as Baltoji brienė or Enbo galdebær. These diverse names reflect the plant's widespread presence across different cultures and geographies.
Sources: Catalogue of Life (COL)
Synonyms
Bryonia alba is a botanical name that is frequently encountered in medicinal and horticultural studies. It is important to note that this species is also widely recognized by its synonym, Bryonia vulgaris. Although these two names may appear different, they both refer to the exact same climbing plant. Understanding this nomenclature is essential for researchers to avoid confusion when documenting its properties. Therefore, whether you see it labeled as alba or vulgaris, you are looking at the same organism.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Bryonia alba belongs to the vast kingdom Plantae, representing a diverse group of multicellular organisms. Within this kingdom, the plant is classified under the class Equisetopsida. It further falls into the order Cucurbitales, which helps define its evolutionary lineage. The species is a member of the genus Bryonia, distinguishing it from other related plants. Finally, it is situated within the family Cucurbitaceae, linking it to the broader group of gourd-producing plants.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Cucurbitales |
| Family | Cucurbitaceae |
| Genus | Bryonia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Bryonia alba is primarily distributed throughout the Asia-Temperate regions, spanning across several key territories in Central Asia. Its presence is notably documented within the nations of Kazakhstan, Kyrgyzstan, Turkmenistan, and Uzbekistan. Beyond these central territories, the plant also extends its reach into the Siberian landscape, specifically within the Altay region. This wide geographical spread highlights the adaptability of the species to various environmental conditions across the continent. Consequently, understanding these specific habitats is essential for studying the plant's natural ecological niche.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Bryonia alba is a distinct herbaceous plant characterized by its vigorous development. This species exhibits an obligatory climbing habit, relying on external structures to support its upward movement. As it climbs, the plant typically achieves a height ranging from a minimum of 2 meters to a minimum of 3 meters. In optimal growing conditions, it can reach a maximum height of 4 meters. This combination of growth form and climbing behavior defines its presence in the natural landscape.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Bryonia alba belongs to a genus known for significant pharmacological potential, particularly regarding its cytotoxic properties. Research into related species such as Bryonia dioica has demonstrated that aqueous extracts can effectively induce apoptosis in cancer cell lines like Burkitt's lymphoma. This cell death occurs through the mitochondrial intrinsic pathway, triggered by the activation of specific caspases and the loss of membrane potential. The observed cytotoxic activity is likely driven by bioactive compounds found within the plant, including polyphenols, sterols, and triterpenes. Consequently, these botanical findings suggest that members of the Bryonia genus hold promise as foundational sources for developing novel anti-cancer therapeutics.
Compounds
Bryonia alba is a plant species known to possess a variety of complex chemical constituents. Within its biological makeup, the plant contains specific cucurbitacin saponins known as Brydioside A, Brydioside B, and Brydioside C. In addition to these compounds, the plant is also characterized by the presence of Bryoamaride. Furthermore, the chemical profile of the species includes the specific glycoside Bryodulcosigenin. These diverse secondary metabolites highlight the intricate chemical complexity found within the genus.
Conditions
Bryonia alba is a component of the homeopathic Canova Method, which is indicated for the treatment of cancer and pathologies involving a depressed immune system like AIDS. The medicinal composite containing this plant works by stimulating macrophages and lymphocytes to increase cytotoxic action against tumoral growth. While the abstracts focus on the related species Bryonia dioica for specific cellular studies, the genus is linked to treating Burkitt's lymphoma. Specifically, aqueous extracts of the genus induce apoptosis in Burkitt's lymphoma BL41 cells via the mitochondrial intrinsic pathway. Furthermore, compounds derived from these plants demonstrate potent inhibitory effects on EBV-EA activation induced by TPA.
Preparations
Bryonia alba is prepared as roots to obtain trihydroxyoctadecadienoic acids for treating metabolic abnormalities in diabetic rats. In the study of the "Canova Method" anticancer composite, Bryonia alba is prepared as homeopathic dilutions to stimulate the immune system. Research on the genus also shows that Bryonia dioica is prepared as an aqueous extract to induce apoptosis in lymphoma cells. Furthermore, these dried roots are prepared as a decoction during the water extraction process for phytochemical investigation. Finally, a standardised preparation of Bryonia C-18 fatty acids is utilized to study its effects on thromboxane and prostaglandin profiles.
Parts used
Bryonia alba is a medicinal plant that derives significant therapeutic value from its root. Research indicates that trihydroxyoctadecadienoic acids extracted from these roots can effectively restore disordered lipid metabolism in diabetic subjects. Furthermore, the root serves as the primary source for standardized extracts used to demonstrate potent adaptogenic and restorative properties. These botanical extracts have shown promise in increasing nonspecific resistance to stress and protecting the immune system against harmful stimuli. Whether used to manage metabolic abnormalities or to enhance physical endurance, the bioactive components found in the Bryonia alba root play a crucial role in its pharmacological profile.